Period As Of Details OISHI GROUP PUBLIC COMPANY LIMITED 2022 Company Year 30/09/2022 OISHI GROUP PUBLIC COMPANY LIMITED 2022 Consolidated Year 30/09/2022 OISHI GROUP PUBLIC COMPANY LIMITED 2022
trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from
SNAPSHOT & ANALYSIS CONSOLIDATED P&L SNAPSHOT THB (mn) 1Q 2017/18 4Q 2017/18 1Q 2018/19 QoQ (%) YoY (%) Operating revenue 852 1,128 1,077 -4.6% 26.5% Cost of sales 356 406 392 -3.5% 10.1% Gross profit 496
Consolidated Interim Financial Statements the three-month and the nine-month period ended 30 September 2018, which have been reviewed by the Company’s authorized auditor. The company would like to clarify the
subscribers. However, the scale of overall subsidized campaigns has been controlled. Pricing environment has been stable and slightly improved on the high-end segment after a raise in minimum ARPU of unlimited
MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 31 MARCH 2018 SG&A expense against only 1.5mTHB consolidated EBITDA contribution, since the acquisition was completed only at the very end of the quarter
Period As Of Details EASON & CO PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 EASON & CO PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 EASON & CO PUBLIC COMPANY LIMITED 2023
Period As Of Details BANGKOK BANK PUBLIC COMPANY LIMITED 2023 Audited Company Q2 30/06/2023 BANGKOK BANK PUBLIC COMPANY LIMITED 2023 Audited Consolidated Q2 30/06/2023 BANGKOK BANK PUBLIC COMPANY LIMITED
Period As Of Details MALEE GROUP PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 MALEE GROUP PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 MALEE GROUP PUBLIC COMPANY LIMITED
Period As Of Details MAHACHAI HOSPITAL PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 MAHACHAI HOSPITAL PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 MAHACHAI HOSPITAL PUBLIC